ALB and cancer: The Kaplan-Meier survival curves revealed that patients with serum albumin levels ≤ 4.2 g/dL experienced a lower overall survival rate compared to those with levels > 4.2 g/dL, regardless of the extent of cancer malignancy (Figure 2).